Description:

NSABP PROTOCOL B-38: Treatment Form for Group 1 - Doxorubicin, Cyclophosphamide, and Docetaxel (TAC) - Form T1 NCT00093795 Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD8782BC-197F-2A84-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD8782BC-197F-2A84-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 12/18/14
  2. 1/9/15
  3. 6/16/15
Uploaded on:

June 16, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL B-38: Treatment Form for Group 1 - Doxorubicin, Cyclophosphamide, and Docetaxel (TAC) - Form T1 NCT00093795

No Instruction available.

  1. StudyEvent: NSABP PROTOCOL B-38: Treatment Form for Group 1 - Doxorubicin, Cyclophosphamide, and Docetaxel (TAC) - Form T1
    1. No Instruction available.
Patient demographics
Are data amended? (check box if yes, and circle amended items)
Assessment of Chemotherapy
Agent Name
Was this cycle delayed due to adverse event(s)? (Circle Y or N for Yes, No)
Reason Treatment Ended (or Never Started Select only one)

Similar models